Company Profile

Adagene Inc. (NASDAQ: ADAG)
5:30 PM UTC, 07/03/24
Last: $2.90 Change: -0.09 %Change: -3.01% Volume: 5,291
Detailed Quote
Open: $ 2.99   Volume: 5,291
High: $ 3.05   Yield(%) 0.00
Low: $ 2.88   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 131.91M
EPS ($) -0.84   Shares Out: 44.12M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 12.41
% Price Change (last 13 weeks): -0.33
% Price Change (last 26 weeks): 52.55
% Price Change (last 52 weeks): 103.40
% Price Change (year to date): 54.81
Management Effectiveness
Return on Equity (%): -24.66
Return on Assets (%): -14.13
Return on Invested Capital (%): -43.43
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): -104.61
Operating Profit Margin (%): -150.18
Price & Volume
50-day Moving Average: $2.65
200-day Moving Average: $2.38
Avg. Daily Vol. (last 50 days): 38,644
Avg. Daily Vol. (last 200 days): 53,003
52-wk high: $4.38
52-wk low: $1.10
Bid: $2.88
Ask: $2.90
Company Information
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
Adagene Inc.
Suzhou Industrial Park No. 218 Xingh Street 4/F, Building C14
Suzhou JS 215123

Phone: 86.512.8777.3632
Fax: 86.512.8777.3584
http://www.adagene.com
Per Share Data
Earnings (1year) ($): -0.44
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 1.60
Cash Flow ($): -0.40
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 4.67
Price/Book (x): 1.21
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 3.61
Current Ratio (x): 3.61
LT Debt/Equity (x): 19.44
Total Debt/Equity (x): 31.61



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.